Loading: 100%
AMICUS THERAPEUTICS INC logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 263 (as per Q2 2016)no data available
Sector Biotechnology, HealthcareBiotechnology, Healthcareno data available
Ticker FOLDno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 1705101520
datesClosing price (adj.)
13.10.201714.53
11.10.201714.27
04.10.201716.24
27.09.201714.94
20.09.201714.92
13.09.201713.52
06.09.201714.07
30.08.201714.09
23.08.201712.64
16.08.201712.60
09.08.201712.58
02.08.201713.15
26.07.201713.70
19.07.201713.37
12.07.201713.17
05.07.201710.29
27.06.20179.72
20.06.20179.55
13.06.20178.60
06.06.20178.51
30.05.20177.66
23.05.20178.26
16.05.20177.89
09.05.20176.65
02.05.20177.62
25.04.20177.62
18.04.20177.09
11.04.20176.99
04.04.20177.23
28.03.20177.36
21.03.20176.82
14.03.20177.03
07.03.20177.01
28.02.20176.49
21.02.20176.01
14.02.20176.18
07.02.20176.02
31.01.20175.50
24.01.20175.34
17.01.20175.41
10.01.20175.70
03.01.20175.13
27.12.20164.92
19.12.20164.90
12.12.20165.80
05.12.20165.99
28.11.20168.32
21.11.20168.99
14.11.20169.30
07.11.20167.43
31.10.20166.90
24.10.20167.50
17.10.20166.94
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
14.53n/a
Market Capitalisation
in million USD
2,065n/a
Enterprise Value
in million USD
1,873n/a
Common Shares Outstanding
as per Jul 29, 2016
142,139,451n/a
Preferred Shares Outstanding
as per Jul 29, 2016
n/a
Average Basic Shares Outstanding
TTM
124,569,901n/a
Average Diluted Shares Outstanding
TTM
n/a
Index Membership
n/a
Business Summary
Amicus Therapeutics Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of next-generation medicines.
no data available
Key Financials & Ratios (all figures TTM as per Jun 30, 2016, million USD, full statements further below)
Profit & Loss
Revenues 0n/a
Gross Profit 0n/a
Operating Income -155n/a
EBITDA -153n/a
Net Profit -175n/a
Balance Sheet
Cash and Cash Equivalents 214n/a
Receivables 0n/a
Total Current Assets 218n/a
PP&E 10n/a
Total Assets 914n/a
Accounts Payable 24n/a
Current Debt 0n/a
Total Current Liabilities 80n/a
Long-Term Debt 22n/a
Total Liabilities 596n/a
Total Equity 318n/a
Cash Flow
Depreciation & Amortisation 2n/a
Change in Working Capital 4n/a
Operating Cash Flow -134n/a
Net Change in PP&E and Intangibles -8n/a
Investing Cash Flow -187n/a
Dividends Paid 0n/a
Financing Cash Flow 136n/a
Total Change in Cash -185n/a
Free Cash Flow -156n/a
Profitability Ratios
Gross Margin 0.0%n/a
Operating Margin 0.0%n/a
Net Profit Margin 0.0%n/a
Return on Equity -55.1%n/a
Return on Assets -19.2%n/a
Per Share Figures
Basic EPS -1.41n/a
Diluted EPS n/a
Sales per Share 0.00n/a
Book Value per Share 2.55n/a
FCF per Share -1.25n/a
Dividends per Share 0.00n/a
Price Multiples
Price to Earnings Ratio -10.32n/a
Price to Sales Ratio n/a
Price to Book Value 5.69n/a
Price to Free Cash Flow -11.61n/a
Valuation Metrics
EV/EBITDA -12.25n/a
EV/Sales n/a
Book to Market Value 0.15n/a
Other Ratios
Current Ratio 270.5%n/a
Liabilities to Equity Ratio 187.3%n/a
Debt to Assets Ratio 2.4%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Revenue
64
1
21
18
0
1
0
Sales & Services Revenue
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
Cost of revenue
0
0
0
0
0
0
0
Cost of Goods & Services
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
Gross Profit
64
1
21
18
0
1
0
Other Operating Income
0
0
0
0
0
0
0
Operating Expenses
-70
-57
-72
-71
-63
-70
-126
Selling, General & Administrative
-20
-16
-20
-19
-19
-21
-47
Selling & Marketing
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
Research & Development
-48
-39
-51
-50
-42
-48
-77
Depreciation & Amortization
-2
-2
-2
-2
-2
-2
-2
Provision For Doubtful Accounts
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
Operating Income (Loss)
-6
-56
-51
-53
-62
-69
-126
Non-Operating Income (Loss)
1
1
0
0
0
-1
-1
Interest Expense, net
1
0
0
0
0
-1
-1
Interest Expense
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
0
1
0
0
0
0
0
Pretax Income (Loss), Adjusted
-5
-55
-51
-53
-62
-70
-127
Abnormal Gains (Losses)
-2
-1
3
1
-1
0
-5
Acquired In-Process R&D
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
Pretax Income (Loss)
-7
-56
-48
-52
-63
-70
-132
Income Tax (Expense) Benefit, net
0
1
4
3
4
1
0
Current Income Tax
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
-7
-55
-44
-49
-60
-69
-132
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
-7
-55
-44
-49
-60
-69
-132
Minority Interest
0
0
0
0
0
0
0
Net Income
-7
-55
-44
-49
-60
-69
-132
Preferred Dividends
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
-7
-55
-44
-49
-60
-69
-132
Remarks
restated on Feb 28, 2012 n/a
calculated values,
restated on Mar 13, 2013 n/a
calculated values,
restated on Mar 3, 2014 n/a
calculated values,
restated on Mar 3, 2015 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
107
56
99
82
152
214
Cash & Cash Equivalents
n/a
30
26
34
44
24
69
Short Term Investments
n/a
78
30
65
38
128
145
Accounts & Notes Receivable
n/a
0
5
3
1
0
0
Accounts Receivable, Net
n/a
0
5
3
1
0
0
Notes Receivable, Net
n/a
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
Inventories
n/a
0
0
0
0
0
0
Raw Materials
n/a
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
Other Short Term Assets
n/a
2
6
2
5
3
3
Prepaid Expenses
n/a
2
6
2
5
3
3
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
0
0
0
0
0
0
Total Current Assets
n/a
110
67
105
88
155
217
Property, Plant & Equipment, Net
n/a
3
2
5
4
3
6
Property, Plant & Equipment
n/a
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
0
17
0
Long Term Investments
n/a
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
Other Long Term Assets
n/a
0
1
0
35
35
686
Intangible Assets
n/a
0
0
0
23
23
487
Goodwill
n/a
0
0
0
12
12
198
Other Intangible Assets
n/a
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
0
1
0
1
1
1
Total Noncurrent Assets
n/a
3
3
5
39
55
692
Total Assets
n/a
113
70
110
128
210
908
Liabilities and owners' equity
Payables & Accruals
n/a
8 8290000
10 9708000
9 8845000
10 10162000
16 16345000
32 32216000
Accounts Payable
n/a
8 8290000
10 9708000
9 8845000
10 10162000
16 16345000
32 32216000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Debt
n/a
1 1293000
1 1044000
0 398000
0 299000
4 3840000
0 0
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
7 6640000
9 8504000
0 0
0 0
0 0
41 41400000
Deferred Revenue
n/a
7 6640000
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
0 0
9 8504000
0 0
0 0
0 0
41 41400000
Total Current Liabilities
n/a
16 16223000
19 19256000
9 9243000
10 10461000
20 20185000
74 73616000
Long Term Debt
n/a
1 1044000
0 0
0 299000
14 14174000
11 10510000
0 0
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
30 30351000
21 20947000
31 31326000
57 57177000
57 57094000
496 495689000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
9 9186000
9 9186000
176 176219000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
30 30351000
21 20947000
31 31326000
48 47991000
48 47908000
319 319470000
Total Noncurrent Liabilities
n/a
31 31395000
21 20947000
32 31625000
71 71351000
68 67604000
496 495689000
Total Liabilities
n/a
48 47618000
40 40203000
41 40868000
82 81812000
88 87789000
569 569305000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
291 290654000
300 299692000
388 388095000
424 424272000
570 569758000
919 918760000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Retained Earnings
n/a
-226 -225692000
-270 -270104000
-319 -318889000
-379 -378522000
-447 -447448000
-580 -579566000
Other Equity
n/a
0 -28000
0 4000
0 14000
0 1000
0 -132000
0 -115000
Equity Before Minority Interest
n/a
65 64934000
30 29592000
69 69220000
46 45751000
122 122178000
339 339079000
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Total Equity
n/a
65 64934000
30 29592000
69 69220000
46 45751000
122 122178000
339 339079000
Total Liabilities & Equity
n/a
113 112552000
70 69795000
110 110088000
128 127563000
210 209967000
908 908384000
Remarks restated on n/a restated on Feb 28, 2012 n/a restated on Mar 13, 2013 n/a restated on Mar 3, 2014 n/a restated on Mar 3, 2015 n/a restated on Feb 29, 2016 n/a restated on Aug 9, 2016 n/a
Cash Flow StatementCF data quality: 96% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Net Income/Starting Line
-7
-55
-44
-49
-60
-69
-132
Net Income
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
Depreciation & Amortization
2
2
2
2
2
2
2
Non-Cash Items
8
8
6
6
7
6
16
Stock-Based Compensation
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
Change in Working Capital
-47
31
-13
8
5
9
14
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
Cash from Operating Activities
-43
-14
-49
-34
-46
-52
-100
Change in Fixed Assets & Intangibles
-2
0
-1
-4
-1
0
-5
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
Net Change in Long Term Investment
34
-19
48
-35
27
-107
1
Decrease in Long Term Investment
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
0
0
0
0
-141
Net Cash from Divestitures
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
Other Investing Activities
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
Cash from Investing Activities
32
-19
46
-39
26
-107
-145
Dividends Paid
0
0
0
0
0
0
0
Cash From (Repayment of) Debt
3
-2
-1
0
14
0
39
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
0
45
0
82
15
139
254
Increase in Capital Stock
0
45
0
82
15
139
254
Decrease in Capital Stock
0
0
0
0
0
0
0
Other Financing Activities
0
0
0
0
0
0
-2
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
Cash from Financing Activities
3
44
-1
82
29
139
291
Net Cash Before Disc. Operations and FX
-9
10
-4
9
10
-20
45
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
Net Cash Before FX
-9
10
-4
9
10
-20
45
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
Net Changes in Cash
-9
10
-4
9
10
-20
45
Remarks
restated on Feb 28, 2012 n/a
calculated values,
restated on Mar 13, 2013 n/a
calculated values,
restated on Mar 3, 2014 n/a
calculated values,
restated on Mar 3, 2015 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo